"SMART-FM": Smart-Phone Based Digital Therapeutic for Management of Fibromyalgia
Completed · Phase 2
Conditions studied: Fibromyalgia
In brief
This is a non-significant risk, multi-center, randomized, active-controlled study to compare the effectiveness of two digital therapies in the management of fibromyalgia over 12 weeks. The primary endpoint is mean change from baseline to Week 12 in the weekly revised Fibromyalgia Impact Questionnaire (FIQ-R) total score.
Key facts
- Study ID
- NCT05005351
- Run by
- Swing Therapeutics, Inc.
- People needed
- 67
- Starts
- 2020-10-28
- Expected to finish
- 2021-07-09
- Last updated by the study team
- 2023-08-01
Who can join
Age: 22 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Excell Research, Inc. — Oceanside, California, United States
- Superior Research LLC — Sacramento, California, United States
- Clinical Neuroscience Solutions, Inc. — Orlando, Florida, United States
- Upstate Clinical Research Associates LLC — Williamsville, New York, United States
- University of Cincinnati Physicians Company, LLC — Cincinnati, Ohio, United States
- Neuro-Behavioral Clinical Research, Inc. — North Canton, Ohio, United States
- Lehigh Center for Clinical Research — Allentown, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.